Vident Advisory, LLC Mesoblast LTD Transaction History

Vident Advisory, LLC

  • $3.62 Trillion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Feb 21, 2024
BUY
$1.22 - $4.83 $26,341 - $104,284
21,591 New
21,591 $26.6 Million
Q3 2023

Nov 14, 2023
BUY
$1.22 - $4.83 $26,341 - $104,284
21,591 New
21,591 $26.6 Million

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email